Enlivex Issues Urgent Statement on Fraudulent News Dissemination
Portfolio Pulse from
Enlivex Therapeutics Ltd. has issued a statement refuting false reports about suspending its stock trading due to an internal investigation. The company confirms that its operations and stock trading on NASDAQ and TASE continue as usual.
February 18, 2025 | 11:30 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Enlivex Therapeutics Ltd. has denied false reports about suspending its stock trading. The company assures that its operations and trading on NASDAQ and TASE are unaffected.
The false report could have caused temporary confusion among investors, but the company's prompt clarification should stabilize any potential volatility. The stock price is likely to remain stable as the company continues normal operations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100